Amneal Pharmaceuticals, Inc.AMRXNASDAQ
LOADING
|||
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$2.79B
↑ 58% above average
Average (9y)
$1.77B
Historical baseline
Range
High:$2.79B
Low:$866.28M
CAGR
+13.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.79B | +16.7% |
| 2023 | $2.39B | +8.2% |
| 2022 | $2.21B | +5.7% |
| 2021 | $2.09B | +5.1% |
| 2020 | $1.99B | +22.5% |
| 2019 | $1.63B | -2.2% |
| 2018 | $1.66B | +60.9% |
| 2017 | $1.03B | +1.5% |
| 2016 | $1.02B | +17.5% |
| 2015 | $866.28M | - |